Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 753 entries
Sorted by: Best Match Show Resources per page
[Esophageal cancer].

Nihon rinsho. Japanese journal of clinical medicine

Ishigami K.
PMID: 5430809
Nihon Rinsho. 1970 Mar 25;28:1152-3.

No abstract available.

Cite
Ishigami K. [Esophageal cancer]. Nihon Rinsho. 1970;28:1152-3
Ishigami, K. (1970). [Esophageal cancer]. Nihon rinsho. Japanese journal of clinical medicine, 281152-3.
Ishigami, K. "[Esophageal cancer]." Nihon rinsho. Japanese journal of clinical medicine vol. 28 (1970): 1152-3.
Ishigami K. [Esophageal cancer]. Nihon Rinsho. 1970 Mar 25;28:1152-3. Japanese. PMID: 5430809.
Copy Download .nbib Format: NLM
Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia.

Clinical and translational gastroenterology

Ishigami H, Matsumura T, Kasamatsu S, Hamanaka S, Taida T, Okimoto K, Saito K, Minemura S, Maruoka D, Nakagawa T, Katsuno T, Fujie M, Arai M.
PMID: 28383567
Clin Transl Gastroenterol. 2017 Apr 06;8(4):e83. doi: 10.1038/ctg.2017.12.

OBJECTIVES: The pathophysiology of functional dyspepsia (FD) is not fully understood. Impaired duodenal mucosal integrity characterized by increased mucosal permeability and/or low-grade inflammation was reported as potentially important etiologies. We aimed to determine the utility of a recently developed...

Cite
Ishigami H, Matsumura T, Kasamatsu S, et al. Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia. Clin Transl Gastroenterol. 2017;8(4):e83doi: 10.1038/ctg.2017.12.
Ishigami, H., Matsumura, T., Kasamatsu, S., Hamanaka, S., Taida, T., Okimoto, K., Saito, K., Minemura, S., Maruoka, D., Nakagawa, T., Katsuno, T., Fujie, M., & Arai, M. (2017). Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia. Clinical and translational gastroenterology, 8(4), e83. https://doi.org/10.1038/ctg.2017.12
Ishigami, Hideaki, et al. "Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia." Clinical and translational gastroenterology vol. 8,4 (2017): e83. doi: https://doi.org/10.1038/ctg.2017.12
Ishigami H, Matsumura T, Kasamatsu S, Hamanaka S, Taida T, Okimoto K, Saito K, Minemura S, Maruoka D, Nakagawa T, Katsuno T, Fujie M, Arai M. Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia. Clin Transl Gastroenterol. 2017 Apr 06;8(4):e83. doi: 10.1038/ctg.2017.12. PMID: 28383567; PMCID: PMC5415894.
Copy Download .nbib Format: NLM
Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa).

Journal of arrhythmia

Hatori Y, Sakai H, Kunishima T, Hatori N, Chen L, Ishigami T, Satoh N.
PMID: 28416976
J Arrhythm. 2017 Apr;33(2):111-116. doi: 10.1016/j.joa.2016.07.008. Epub 2016 Aug 23.

BACKGROUND: Atrial fibrillation (AF) is one of the most prevalent cardiac arrhythmias associated with substantially increased risks of ischemic stroke and thromboembolism. Oral anticoagulants (OACs) are the cornerstone of AF management and effectively prevent AF-related stroke. As new non-vitamin...

Cite
Hatori Y, Sakai H, Kunishima T, et al. Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa). J Arrhythm. 2016;33(2):111-116doi: 10.1016/j.joa.2016.07.008.
Hatori, Y., Sakai, H., Kunishima, T., Hatori, N., Chen, L., Ishigami, T., Satoh, N. (2017). Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa). Journal of arrhythmia, 33(2), 111-116. https://doi.org/10.1016/j.joa.2016.07.008
Hatori, Yutaka, et al. "Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa)." Journal of arrhythmia vol. 33,2 (2017): 111-116. doi: https://doi.org/10.1016/j.joa.2016.07.008
Hatori Y, Sakai H, Kunishima T, Hatori N, Chen L, Ishigami T, Satoh N. Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa). J Arrhythm. 2017 Apr;33(2):111-116. doi: 10.1016/j.joa.2016.07.008. Epub 2016 Aug 23. PMID: 28416976; PMCID: PMC5388051.
Copy Download .nbib Format: NLM
Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs.

Hepatology international

Kamei H, Masuda S, Nakamura T, Ishigami M, Fujimoto Y, Ogura Y, Oike F, Takada Y, Hamajima N.
PMID: 26201930
Hepatol Int. 2013 Jul;7(3):916-22. doi: 10.1007/s12072-013-9443-2. Epub 2013 Jul 31.

PURPOSE: Despite improvements in immunosuppressive therapy, acute cellular rejection (ACR) remains an important cause of graft loss in patients undergoing liver transplantation. Recently, associations between cytokine gene polymorphisms in recipients and the occurrence of ACR have been reported. However,...

Cite
Kamei H, Masuda S, Nakamura T, et al. Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs. Hepatol Int. 2013;7(3):916-22doi: 10.1007/s12072-013-9443-2.
Kamei, H., Masuda, S., Nakamura, T., Ishigami, M., Fujimoto, Y., Ogura, Y., Oike, F., Takada, Y., & Hamajima, N. (2013). Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs. Hepatology international, 7(3), 916-22. https://doi.org/10.1007/s12072-013-9443-2
Kamei, Hideya, et al. "Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs." Hepatology international vol. 7,3 (2013): 916-22. doi: https://doi.org/10.1007/s12072-013-9443-2
Kamei H, Masuda S, Nakamura T, Ishigami M, Fujimoto Y, Ogura Y, Oike F, Takada Y, Hamajima N. Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs. Hepatol Int. 2013 Jul;7(3):916-22. doi: 10.1007/s12072-013-9443-2. Epub 2013 Jul 31. PMID: 26201930.
Copy Download .nbib Format: NLM
Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial.

Hepatology research : the official journal of the Japan Society of Hepatology

Otsuji K, Takai K, Nishigaki Y, Shimizu S, Hayashi H, Imai K, Suzuki Y, Hanai T, Ideta T, Miyazaki T, Tomita E, Shimizu M, Moriwaki H.
PMID: 24961745
Hepatol Res. 2015 May;45(5):514-22. doi: 10.1111/hepr.12376. Epub 2014 Jul 24.

AIM: Transcatheter arterial chemoembolization (TACE) and transarterial infusion chemotherapy (TAI) are the main therapeutic strategies for treatment of advanced hepatocellular carcinoma (HCC). We conducted a randomized controlled trial to compare the efficacy and safety of cisplatin and miriplatin in...

Cite
Otsuji K, Takai K, Nishigaki Y, et al. Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial. Hepatol Res. 2014;45(5):514-22doi: 10.1111/hepr.12376.
Otsuji, K., Takai, K., Nishigaki, Y., Shimizu, S., Hayashi, H., Imai, K., Suzuki, Y., Hanai, T., Ideta, T., Miyazaki, T., Tomita, E., Shimizu, M., & Moriwaki, H. (2015). Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial. Hepatology research : the official journal of the Japan Society of Hepatology, 45(5), 514-22. https://doi.org/10.1111/hepr.12376
Otsuji, Kentarou, et al. "Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial." Hepatology research : the official journal of the Japan Society of Hepatology vol. 45,5 (2015): 514-22. doi: https://doi.org/10.1111/hepr.12376
Otsuji K, Takai K, Nishigaki Y, Shimizu S, Hayashi H, Imai K, Suzuki Y, Hanai T, Ideta T, Miyazaki T, Tomita E, Shimizu M, Moriwaki H. Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial. Hepatol Res. 2015 May;45(5):514-22. doi: 10.1111/hepr.12376. Epub 2014 Jul 24. PMID: 24961745.
Copy Download .nbib Format: NLM
Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques.

World journal of hepatology

Imai N, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Hirooka Y, Goto H.
PMID: 25544871
World J Hepatol. 2014 Dec 27;6(12):844-50. doi: 10.4254/wjh.v6.i12.844.

Hepatocellular carcinoma (HCC) is one of the most common malignant diseases worldwide. While curative therapies, including resection, liver transplantation, and percutaneous ablation (percutaneous ethanol injection and radiofrequency ablation), are applicable for only a portion of the HCC population, transcatheter...

Cite
Imai N, Ishigami M, Ishizu Y, et al. Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques. World J Hepatol. 2014;6(12):844-50doi: 10.4254/wjh.v6.i12.844.
Imai, N., Ishigami, M., Ishizu, Y., Kuzuya, T., Honda, T., Hayashi, K., Hirooka, Y., & Goto, H. (2014). Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques. World journal of hepatology, 6(12), 844-50. https://doi.org/10.4254/wjh.v6.i12.844
Imai, Norihiro, et al. "Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques." World journal of hepatology vol. 6,12 (2014): 844-50. doi: https://doi.org/10.4254/wjh.v6.i12.844
Imai N, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Hirooka Y, Goto H. Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques. World J Hepatol. 2014 Dec 27;6(12):844-50. doi: 10.4254/wjh.v6.i12.844. PMID: 25544871; PMCID: PMC4269903.
Copy Download .nbib Format: NLM
Cartilage Intermediate Layer Protein and Asporin Polymorphisms Are Independent Risk Factors of Lumbar Disc Degeneration in Male Collegiate Athletes.

Cartilage

Min SK, Nakazato K, Ishigami H, Hiranuma K.
PMID: 26069683
Cartilage. 2014 Jan;5(1):37-42. doi: 10.1177/1947603513500786.

OBJECTIVE: Lumbar disc degeneration (LDDG), recently reported to have strong genetic determinants, is a major cause of discopathy and lower back pain. However, most studies have only evaluated the effects of a single susceptibility polymorphism. Our purpose was to...

Cite
Min SK, Nakazato K, Ishigami H, et al. Cartilage Intermediate Layer Protein and Asporin Polymorphisms Are Independent Risk Factors of Lumbar Disc Degeneration in Male Collegiate Athletes. Cartilage. 2014;5(1):37-42doi: 10.1177/1947603513500786.
Min, S. K., Nakazato, K., Ishigami, H., & Hiranuma, K. (2014). Cartilage Intermediate Layer Protein and Asporin Polymorphisms Are Independent Risk Factors of Lumbar Disc Degeneration in Male Collegiate Athletes. Cartilage, 5(1), 37-42. https://doi.org/10.1177/1947603513500786
Min, Seok-Ki, et al. "Cartilage Intermediate Layer Protein and Asporin Polymorphisms Are Independent Risk Factors of Lumbar Disc Degeneration in Male Collegiate Athletes." Cartilage vol. 5,1 (2014): 37-42. doi: https://doi.org/10.1177/1947603513500786
Min SK, Nakazato K, Ishigami H, Hiranuma K. Cartilage Intermediate Layer Protein and Asporin Polymorphisms Are Independent Risk Factors of Lumbar Disc Degeneration in Male Collegiate Athletes. Cartilage. 2014 Jan;5(1):37-42. doi: 10.1177/1947603513500786. PMID: 26069683; PMCID: PMC4297097.
Copy Download .nbib Format: NLM
The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons.

FEBS open bio

Honda D, Ishigaki S, Iguchi Y, Fujioka Y, Udagawa T, Masuda A, Ohno K, Katsuno M, Sobue G.
PMID: 24319651
FEBS Open Bio. 2013 Nov 20;4:1-10. doi: 10.1016/j.fob.2013.11.001. eCollection 2013.

TDP-43 and FUS are linked to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), and loss of function of either protein contributes to these neurodegenerative conditions. To elucidate the TDP-43- and FUS-regulated pathophysiological RNA metabolism cascades, we assessed...

Cite
Honda D, Ishigaki S, Iguchi Y, et al. The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons. FEBS Open Bio. 2013;4:1-10doi: 10.1016/j.fob.2013.11.001.
Honda, D., Ishigaki, S., Iguchi, Y., Fujioka, Y., Udagawa, T., Masuda, A., Ohno, K., Katsuno, M., & Sobue, G. (2013). The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons. FEBS open bio, 41-10. https://doi.org/10.1016/j.fob.2013.11.001
Honda, Daiyu, et al. "The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons." FEBS open bio vol. 4 (2013): 1-10. doi: https://doi.org/10.1016/j.fob.2013.11.001
Honda D, Ishigaki S, Iguchi Y, Fujioka Y, Udagawa T, Masuda A, Ohno K, Katsuno M, Sobue G. The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons. FEBS Open Bio. 2013 Nov 20;4:1-10. doi: 10.1016/j.fob.2013.11.001. eCollection 2013. PMID: 24319651; PMCID: PMC3851184.
Copy Download .nbib Format: NLM
Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes.

World journal of gastrointestinal oncology

Yamaguchi H, Kitayama J, Ishigami H, Kazama S, Nozawa H, Kawai K, Hata K, Kiyomatsu T, Tanaka T, Tanaka J, Nishikawa T, Otani K, Yasuda K, Ishihara S, Sunami E, Watanabe T.
PMID: 26600928
World J Gastrointest Oncol. 2015 Nov 15;7(11):285-91. doi: 10.4251/wjgo.v7.i11.285.

The effect of chemotherapy on peritoneal carcinomatosis (PC) of gastric cancer remains unclear. Recently, the intraperitoneal (IP) administration of taxanes [e.g., paclitaxel (PTX) and docetaxel (DOC)] during the perioperative period has shown promising results. Herein, we summarized the rationale...

Cite
Yamaguchi H, Kitayama J, Ishigami H, et al. Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes. World J Gastrointest Oncol. 2015;7(11):285-91doi: 10.4251/wjgo.v7.i11.285.
Yamaguchi, H., Kitayama, J., Ishigami, H., Kazama, S., Nozawa, H., Kawai, K., Hata, K., Kiyomatsu, T., Tanaka, T., Tanaka, J., Nishikawa, T., Otani, K., Yasuda, K., Ishihara, S., Sunami, E., & Watanabe, T. (2015). Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes. World journal of gastrointestinal oncology, 7(11), 285-91. https://doi.org/10.4251/wjgo.v7.i11.285
Yamaguchi, Hironori, et al. "Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes." World journal of gastrointestinal oncology vol. 7,11 (2015): 285-91. doi: https://doi.org/10.4251/wjgo.v7.i11.285
Yamaguchi H, Kitayama J, Ishigami H, Kazama S, Nozawa H, Kawai K, Hata K, Kiyomatsu T, Tanaka T, Tanaka J, Nishikawa T, Otani K, Yasuda K, Ishihara S, Sunami E, Watanabe T. Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes. World J Gastrointest Oncol. 2015 Nov 15;7(11):285-91. doi: 10.4251/wjgo.v7.i11.285. PMID: 26600928; PMCID: PMC4644851.
Copy Download .nbib Format: NLM
Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging.

Nagoya journal of medical science

Kawamura A, Satake H, Ishigaki S, Ikeda M, Kimura R, Shimamoto K, Naganawa S.
PMID: 26412889
Nagoya J Med Sci. 2015 Aug;77(3):425-37.

This retrospective study assessed the effects of menopausal status and menstrual cycle on background parenchymal enhancement (BPE) of breast magnetic resonance imaging (MRI), and investigated whether the degree of BPE can be predicted by findings of mammography, ultrasonography (US),...

Cite
Kawamura A, Satake H, Ishigaki S, et al. Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging. Nagoya J Med Sci. 2015;77(3):425-37
Kawamura, A., Satake, H., Ishigaki, S., Ikeda, M., Kimura, R., Shimamoto, K., & Naganawa, S. (2015). Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging. Nagoya journal of medical science, 77(3), 425-37.
Kawamura, Akiko, et al. "Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging." Nagoya journal of medical science vol. 77,3 (2015): 425-37.
Kawamura A, Satake H, Ishigaki S, Ikeda M, Kimura R, Shimamoto K, Naganawa S. Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging. Nagoya J Med Sci. 2015 Aug;77(3):425-37. PMID: 26412889; PMCID: PMC4574330.
Copy Download .nbib Format: NLM
Retinitis Pigmentosa with EYS Mutations Is the Most Prevalent Inherited Retinal Dystrophy in Japanese Populations.

Journal of ophthalmology

Arai Y, Maeda A, Hirami Y, Ishigami C, Kosugi S, Mandai M, Kurimoto Y, Takahashi M.
PMID: 26161267
J Ophthalmol. 2015;2015:819760. doi: 10.1155/2015/819760. Epub 2015 Jun 16.

The aim of this study was to gain information about disease prevalence and to identify the responsible genes for inherited retinal dystrophies (IRD) in Japanese populations. Clinical and molecular evaluations were performed on 349 patients with IRD. For segregation...

Cite
Arai Y, Maeda A, Hirami Y, et al. Retinitis Pigmentosa with EYS Mutations Is the Most Prevalent Inherited Retinal Dystrophy in Japanese Populations. J Ophthalmol. 2015;2015:819760doi: 10.1155/2015/819760.
Arai, Y., Maeda, A., Hirami, Y., Ishigami, C., Kosugi, S., Mandai, M., Kurimoto, Y., & Takahashi, M. (2015). Retinitis Pigmentosa with EYS Mutations Is the Most Prevalent Inherited Retinal Dystrophy in Japanese Populations. Journal of ophthalmology, 2015819760. https://doi.org/10.1155/2015/819760
Arai, Yuuki, et al. "Retinitis Pigmentosa with EYS Mutations Is the Most Prevalent Inherited Retinal Dystrophy in Japanese Populations." Journal of ophthalmology vol. 2015 (2015): 819760. doi: https://doi.org/10.1155/2015/819760
Arai Y, Maeda A, Hirami Y, Ishigami C, Kosugi S, Mandai M, Kurimoto Y, Takahashi M. Retinitis Pigmentosa with EYS Mutations Is the Most Prevalent Inherited Retinal Dystrophy in Japanese Populations. J Ophthalmol. 2015;2015:819760. doi: 10.1155/2015/819760. Epub 2015 Jun 16. PMID: 26161267; PMCID: PMC4487330.
Copy Download .nbib Format: NLM
Scattering strength of the scatterer inducing variability in graphene on silicon oxide.

Journal of physics. Condensed matter : an Institute of Physics journal

Katoch J, Le D, Singh S, Rao R, Rahman TS, Ishigami M.
PMID: 26902181
J Phys Condens Matter. 2016 Mar 23;28(11):115301. doi: 10.1088/0953-8984/28/11/115301. Epub 2016 Feb 23.

Large variability of carrier mobility of graphene-based field effect transistors hampers graphene science and technology. We show that the number of the scatterer responsible for the observed variability on graphene devices on silicon oxide can be determined by finding...

Cite
Katoch J, Le D, Singh S, et al. Scattering strength of the scatterer inducing variability in graphene on silicon oxide. J Phys Condens Matter. 2016;28(11):115301doi: 10.1088/0953-8984/28/11/115301.
Katoch, J., Le, D., Singh, S., Rao, R., Rahman, T. S., & Ishigami, M. (2016). Scattering strength of the scatterer inducing variability in graphene on silicon oxide. Journal of physics. Condensed matter : an Institute of Physics journal, 28(11), 115301. https://doi.org/10.1088/0953-8984/28/11/115301
Katoch, Jyoti, et al. "Scattering strength of the scatterer inducing variability in graphene on silicon oxide." Journal of physics. Condensed matter : an Institute of Physics journal vol. 28,11 (2016): 115301. doi: https://doi.org/10.1088/0953-8984/28/11/115301
Katoch J, Le D, Singh S, Rao R, Rahman TS, Ishigami M. Scattering strength of the scatterer inducing variability in graphene on silicon oxide. J Phys Condens Matter. 2016 Mar 23;28(11):115301. doi: 10.1088/0953-8984/28/11/115301. Epub 2016 Feb 23. PMID: 26902181.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 753 entries